Phospho-Trk B (Tyr706/Tyr707) Antibody - #AF3942
Product: | Phospho-Trk B (Tyr706/Tyr707) Antibody |
Catalog: | AF3942 |
Description: | Rabbit polyclonal antibody to Phospho-Trk B (Tyr706/Tyr707) |
Application: | ELISA(peptide) |
Reactivity: | Human |
Mol.Wt.: | 92kD(Calculated). |
Uniprot: | Q16620 |
RRID: | AB_2847665 |
Product Info
*The optimal dilutions should be determined by the end user.
*Tips:
WB: For western blot detection of denatured protein samples. IHC: For immunohistochemical detection of paraffin sections (IHC-p) or frozen sections (IHC-f) of tissue samples. IF/ICC: For immunofluorescence detection of cell samples. ELISA(peptide): For ELISA detection of antigenic peptide.
Cite Format: Affinity Biosciences Cat# AF3942, RRID:AB_2847665.
Fold/Unfold
AI848316; BDNF tropomyosine receptor kinase B; BDNF/NT 3 growth factors receptor; BDNF/NT-3 growth factors receptor; Brain derived neurotrophic factor receptor; C030027L06Rik; EC 2.7.10.1; GP145 TrkB; GP145-TrkB; GP145-TrkB/GP95-TrkB; GP95 TrkB; Neurotrophic receptor tyrosine kinase 2; Neurotrophic tyrosine kinase receptor type 2; Neurotrophin receptor tyrosine kinase type 2; NTRK 2; Ntrk2; NTRK2_HUMAN; Obesity, hyperphagia, and developmental delay, included; RATTRKB1; Tkrb; Trk B; Trk-B; TRKB; TrkB tyrosine kinase; TRKB1; Tropomyosin related kinase B; tyrosine kinase receptor B; Tyrosine receptor kinase B;
Immunogens
A synthesized peptide derived from human Trk B around the phosphorylation site of Tyr706/Tyr707.
Isoform TrkB is expressed in the central and peripheral nervous system. In the central nervous system (CNS), expression is observed in the cerebral cortex, hippocampus, thalamus, choroid plexus, granular layer of the cerebellum, brain stem, and spinal cord. In the peripheral nervous system, it is expressed in many cranial ganglia, the ophthalmic nerve, the vestibular system, multiple facial structures, the submaxillary glands, and dorsal root ganglia. Isoform TrkB-T1 is mainly expressed in the brain but also detected in other tissues including pancreas, kidney and heart. Isoform TrkB-T-Shc is predominantly expressed in the brain.
- Q16620 NTRK2_HUMAN:
- Protein BLAST With
- NCBI/
- ExPASy/
- Uniprot
MSSWIRWHGPAMARLWGFCWLVVGFWRAAFACPTSCKCSASRIWCSDPSPGIVAFPRLEPNSVDPENITEIFIANQKRLEIINEDDVEAYVGLRNLTIVDSGLKFVAHKAFLKNSNLQHINFTRNKLTSLSRKHFRHLDLSELILVGNPFTCSCDIMWIKTLQEAKSSPDTQDLYCLNESSKNIPLANLQIPNCGLPSANLAAPNLTVEEGKSITLSCSVAGDPVPNMYWDVGNLVSKHMNETSHTQGSLRITNISSDDSGKQISCVAENLVGEDQDSVNLTVHFAPTITFLESPTSDHHWCIPFTVKGNPKPALQWFYNGAILNESKYICTKIHVTNHTEYHGCLQLDNPTHMNNGDYTLIAKNEYGKDEKQISAHFMGWPGIDDGANPNYPDVIYEDYGTAANDIGDTTNRSNEIPSTDVTDKTGREHLSVYAVVVIASVVGFCLLVMLFLLKLARHSKFGMKGPASVISNDDDSASPLHHISNGSNTPSSSEGGPDAVIIGMTKIPVIENPQYFGITNSQLKPDTFVQHIKRHNIVLKRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDASDNARKDFHREAELLTNLQHEHIVKFYGVCVEGDPLIMVFEYMKHGDLNKFLRAHGPDAVLMAEGNPPTELTQSQMLHIAQQIAAGMVYLASQHFVHRDLATRNCLVGENLLVKIGDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSLGVVLWEIFTYGKQPWYQLSNNEVIECITQGRVLQRPRTCPQEVYELMLGCWQREPHMRKNIKGIHTLLQNLAKASPVYLDILG
PTMs - Q16620 As Substrate
Site | PTM Type | Enzyme | Source |
---|---|---|---|
N67 | N-Glycosylation | Uniprot | |
N95 | N-Glycosylation | Uniprot | |
N121 | N-Glycosylation | Uniprot | |
S141 | Phosphorylation | Uniprot | |
T151 | Phosphorylation | Uniprot | |
S153 | Phosphorylation | Uniprot | |
T161 | Phosphorylation | Uniprot | |
N178 | N-Glycosylation | Uniprot | |
N205 | N-Glycosylation | Uniprot | |
N241 | N-Glycosylation | Uniprot | |
T253 | Phosphorylation | Uniprot | |
N254 | N-Glycosylation | Uniprot | |
S256 | Phosphorylation | Uniprot | |
S257 | Phosphorylation | Uniprot | |
S260 | Phosphorylation | Uniprot | |
N280 | N-Glycosylation | Uniprot | |
N338 | N-Glycosylation | Uniprot | |
N412 | N-Glycosylation | Uniprot | |
K461 | Acetylation | Uniprot | |
S479 | Phosphorylation | Uniprot | |
Y490 | Phosphorylation | Uniprot | |
T506 | Phosphorylation | Uniprot | |
Y516 | Phosphorylation | Q16620 (NTRK2) | Uniprot |
Y558 | Phosphorylation | Uniprot | |
T573 | Phosphorylation | Uniprot | |
Y670 | Phosphorylation | Uniprot | |
Y674 | Phosphorylation | Uniprot | |
Y675 | Phosphorylation | Uniprot | |
S698 | Phosphorylation | Uniprot | |
Y702 | Phosphorylation | Uniprot | |
Y706 | Phosphorylation | Uniprot | |
Y707 | Phosphorylation | Uniprot | |
Y785 | Phosphorylation | Uniprot | |
Y817 | Phosphorylation | Uniprot |
PTMs - Q16620 As Enzyme
Substrate | Site | Source |
---|---|---|
O43559 (FRS3) | Y417 | Uniprot |
O43559 (FRS3) | Y455 | Uniprot |
P22001 (KCNA3) | Y161 | Uniprot |
P22001 (KCNA3) | Y162 | Uniprot |
P22001 (KCNA3) | Y163 | Uniprot |
P22001 (KCNA3) | Y499 | Uniprot |
Q00535 (CDK5) | Y15 | Uniprot |
Q13009 (TIAM1) | Y829 | Uniprot |
Q16620 (NTRK2) | Y516 | Uniprot |
Q16620-4 (NTRK2) | Y532 | Uniprot |
Q16620-1 (NTRK2) | Y702 | Uniprot |
Q16620-1 (NTRK2) | Y706 | Uniprot |
Q16620-1 (NTRK2) | Y707 | Uniprot |
Q16620-4 (NTRK2) | Y718 | Uniprot |
Q16620-4 (NTRK2) | Y722 | Uniprot |
Q16620-4 (NTRK2) | Y723 | Uniprot |
Q16620-1 (NTRK2) | Y817 | Uniprot |
Q16620-4 (NTRK2) | Y833 | Uniprot |
Q92529-2 (SHC3) | Y218 | Uniprot |
Q92529-2 (SHC3) | Y219 | Uniprot |
Q92529-2 (SHC3) | Y256 | Uniprot |
Q92529-2 (SHC3) | Y257 | Uniprot |
Q92529-2 (SHC3) | Y283 | Uniprot |
Q92529-2 (SHC3) | Y301 | Uniprot |
Research Backgrounds
Receptor tyrosine kinase involved in the development and the maturation of the central and the peripheral nervous systems through regulation of neuron survival, proliferation, migration, differentiation, and synapse formation and plasticity (By similarity). Receptor for BDNF/brain-derived neurotrophic factor and NTF4/neurotrophin-4. Alternatively can also bind NTF3/neurotrophin-3 which is less efficient in activating the receptor but regulates neuron survival through NTRK2. Upon ligand-binding, undergoes homodimerization, autophosphorylation and activation. Recruits, phosphorylates and/or activates several downstream effectors including SHC1, FRS2, SH2B1, SH2B2 and PLCG1 that regulate distinct overlapping signaling cascades. Through SHC1, FRS2, SH2B1, SH2B2 activates the GRB2-Ras-MAPK cascade that regulates for instance neuronal differentiation including neurite outgrowth. Through the same effectors controls the Ras-PI3 kinase-AKT1 signaling cascade that mainly regulates growth and survival. Through PLCG1 and the downstream protein kinase C-regulated pathways controls synaptic plasticity. Thereby, plays a role in learning and memory by regulating both short term synaptic function and long-term potentiation. PLCG1 also leads to NF-Kappa-B activation and the transcription of genes involved in cell survival. Hence, it is able to suppress anoikis, the apoptosis resulting from loss of cell-matrix interactions. May also play a role in neutrophin-dependent calcium signaling in glial cells and mediate communication between neurons and glia.
Phosphorylated. Undergoes ligand-mediated autophosphorylation that is required for interaction with SHC1 and PLCG1 and other downstream effectors. Isoform TrkB-T-Shc is not phosphorylated.
Ubiquitinated. Undergoes polyubiquitination upon activation; regulated by NGFR. Ubiquitination regulates the internalization of the receptor (By similarity).
Cell membrane>Single-pass type I membrane protein. Endosome membrane>Single-pass type I membrane protein. Early endosome membrane. Cell projection>Axon. Cell projection>Dendrite. Cytoplasm>Perinuclear region. Cell junction>Synapse>Postsynaptic density.
Note: Internalized to endosomes upon ligand-binding.
Isoform TrkB is expressed in the central and peripheral nervous system. In the central nervous system (CNS), expression is observed in the cerebral cortex, hippocampus, thalamus, choroid plexus, granular layer of the cerebellum, brain stem, and spinal cord. In the peripheral nervous system, it is expressed in many cranial ganglia, the ophthalmic nerve, the vestibular system, multiple facial structures, the submaxillary glands, and dorsal root ganglia. Isoform TrkB-T1 is mainly expressed in the brain but also detected in other tissues including pancreas, kidney and heart. Isoform TrkB-T-Shc is predominantly expressed in the brain.
Exists in a dynamic equilibrium between monomeric (low affinity) and dimeric (high affinity) structures. Interacts (phosphorylated upon activation by BDNF) with SHC1; mediates SHC1 phosphorylation and activation. Interacts (phosphorylated upon activation by BDNF) with PLCG1 and/or PLCG2; mediates PLCG1 phosphorylation and activation. Interacts with SH2B1 and SH2B2. Interacts with NGFR; may regulate the ligand specificity of the receptor (By similarity). Interacts with SORCS2; this interaction is important for normal targeting to post-synaptic densities in response to high-frequency stimulation (By similarity). Interacts (phosphorylated upon ligand-binding) with SH2D1A; regulates NTRK2. Interacts with SQSTM1 and KIDINS220 (By similarity). Interacts (phosphorylated upon ligand-binding) with FRS2; activates the MAPK signaling pathway. Interacts with APPL1 (By similarity). Interacts with MAPK8IP3/JIP3 and KLC1; interaction with KLC1 is mediated by MAPK8IP3/JIP3 (By similarity). Interacts with SORL1; this interaction facilitates NTRK2 trafficking between synaptic plasma membranes, postsynaptic densities and cell soma, hence positively regulates BDNF signaling (By similarity).
Belongs to the protein kinase superfamily. Tyr protein kinase family. Insulin receptor subfamily.
Research Fields
· Environmental Information Processing > Signal transduction > MAPK signaling pathway. (View pathway)
· Environmental Information Processing > Signal transduction > Ras signaling pathway. (View pathway)
· Environmental Information Processing > Signal transduction > PI3K-Akt signaling pathway. (View pathway)
· Human Diseases > Substance dependence > Alcoholism.
· Organismal Systems > Nervous system > Neurotrophin signaling pathway. (View pathway)
Restrictive clause
Affinity Biosciences tests all products strictly. Citations are provided as a resource for additional applications that have not been validated by Affinity Biosciences. Please choose the appropriate format for each application and consult Materials and Methods sections for additional details about the use of any product in these publications.
For Research Use Only.
Not for use in diagnostic or therapeutic procedures. Not for resale. Not for distribution without written consent. Affinity Biosciences will not be held responsible for patent infringement or other violations that may occur with the use of our products. Affinity Biosciences, Affinity Biosciences Logo and all other trademarks are the property of Affinity Biosciences LTD.